Alzheimer's Disease Drug Discovery Targeted to the APP mRNA 5'Untranslated Region

Author： Rogers J.T.   Randall J.D.   Eder P.S.   Huang X.   Bush A.I.   Tanzi R.E.   Venti A.   Payton S.M.   Giordano T.   Nagano S.   Cahill C.M.   Moir R.   Lahiri D.K.   Greig N.   Sarang S.S.   Gullans S.R.  

Publisher： Humana Press, Inc

ISSN： 0895-8696

Source： Journal of Molecular Neuroscience, Vol.19, Iss.1-2, 2002-10, pp. : 77-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug discovery targeted to the Alzheimer’s APP mRNA 5′-untranslated region: The action of paroxetine and dimercaptopropanol

By Payton Sandra   Cahill Catherine   Randall Jeffrey   Gullans Steven   Rogers Jack  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 267-275

Humana Press, Inc

Access to resources Recommend Favorite

-Secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease

By Preece P.   Virley D.J.   Costandi M.   Coombes R.   Moss S.J.   Mudge A.W.   Jazin E.   Cairns N.J.  

Molecular Brain Research, Vol. 116, Iss. 1, 2003-08 ,pp. : 155-158

Elsevier

Access to resources Recommend Favorite

PP2A mRNA Expression Is Quantitatively Decreased in Alzheimer's Disease Hippocampus

By Vogelsberg-Ragaglia V.   Schuck T.   Trojanowski J.Q.   Lee V.M.-Y.  

Experimental Neurology, Vol. 168, Iss. 2, 2001-04 ,pp. : 402-412

Elsevier

Access to resources Recommend Favorite

Editorial [ Drug Discovery for Alzheimer's Disease: Filling the Pipeline Guest Editors: Antony R. Horton and Howard M. Fillit ]

By  

Current Alzheimer Research, Vol. 4, Iss. 5, 2007-12 ,pp. : 501-502

Bentham Science Publishers

Access to resources Recommend Favorite

Drug discovery for Alzheimer’s disease: The end of the beginning

By Refolo Lorenzo   Fillit Howard  

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 1-8

Humana Press, Inc

Access to resources Recommend Favorite